Atogepant for the Preventive Treatment of Migraine.

2021 
Abstract Background Atogepant is an oral, small-molecule, calcitonin gene–related peptide receptor antagonist that is being investigated for the preventive treatment of migraine. Methods In a phase...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    14
    References
    2
    Citations
    NaN
    KQI
    []